- Home
- LRMR vs ROMA Comparison
LRMR vs ROMA Comparison
Compare LRMR & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRMR | ROMA |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 503.9M |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LRMR | ROMA |
|---|---|---|
| Price | $3.47 | $7.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 32.2K |
| Earning Date | 05-06-2026 | 12-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $1.16 |
| 52 Week High | $6.42 | $11.77 |
Technical Indicators
Market Signals| Indicator | LRMR | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 57.74 |
| Support Level | $3.10 | $2.00 |
| Resistance Level | $3.74 | $8.53 |
| Average True Range (ATR) | 0.20 | 0.83 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 81.29 | 83.42 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.